جراحة القلب والصدر والأوعية الدموية (طب الاطفال)
معالجة وتحسين وقف النزف
العربية
معالجة وتحسين وقف النزف
/assets/ct/a63ae92c98/images/syn_placeholder_sqr.png

جراحة القلب والصدر والأوعية الدموية (طب الاطفال)

معالجة وتحسين وقف النزف

مضادات انحلال الفبرين

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (يفتح نافذة جديدة)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Source‎: Anesth Analg 2006;102(3):731-7.

مفهرسة‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (يفتح نافذة جديدة)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (يفتح نافذة جديدة)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Source‎: Br J Anaesth 2012;108(5):830-7.

مفهرسة‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (يفتح نافذة جديدة)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (يفتح نافذة جديدة)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Source‎: Ann Thorac Surg 2000;70(4):1308-12.

مفهرسة‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (يفتح نافذة جديدة)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (يفتح نافذة جديدة)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Source‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

مفهرسة‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (يفتح نافذة جديدة)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (يفتح نافذة جديدة)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Source‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

مفهرسة‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (يفتح نافذة جديدة)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (يفتح نافذة جديدة)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Source‎: PLoS One 2015;10(5):e0126514.

مفهرسة‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (يفتح نافذة جديدة)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (يفتح نافذة جديدة)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Source‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

مفهرسة‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (يفتح نافذة جديدة)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (يفتح نافذة جديدة)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Source‎: Br J Anaesth 2013;110(4):615-21.

مفهرسة‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (يفتح نافذة جديدة)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (يفتح نافذة جديدة)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Source‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

مفهرسة‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (يفتح نافذة جديدة)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (يفتح نافذة جديدة)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Source‎: Ann Card Anaesth 2015;18(1):23-6.

مفهرسة‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (يفتح نافذة جديدة)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (يفتح نافذة جديدة)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Source‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

مفهرسة‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (يفتح نافذة جديدة)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (يفتح نافذة جديدة)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Source‎: Eur J Anaesthesiol 2015;32(12):844-50.

مفهرسة‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (يفتح نافذة جديدة)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (يفتح نافذة جديدة)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Source‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

مفهرسة‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (يفتح نافذة جديدة)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (يفتح نافذة جديدة)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Source‎: Ann Card Anaesth 2010;13(2):110-5.

مفهرسة‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (يفتح نافذة جديدة)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (يفتح نافذة جديدة)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Source‎: Anesthesiology 2015;122(4):746-58.

مفهرسة‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (يفتح نافذة جديدة)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (يفتح نافذة جديدة)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Source‎: Ann Thorac Surg 2011;92(3):958-63.

مفهرسة‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (يفتح نافذة جديدة)

العامل السابع المفعَّل المأشوب أ (rFVIIa)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (يفتح نافذة جديدة)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Source‎: Ann Thorac Surg 2007;84(1):161-8.

مفهرسة‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (يفتح نافذة جديدة)

Pediatric off-label use of recombinant factor VIIa. (يفتح نافذة جديدة)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Source‎: Pediatrics 2009;123(3):1066-72.

مفهرسة‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (يفتح نافذة جديدة)

Factor VII for excessive bleeding following congenital heart disease surgery. (يفتح نافذة جديدة)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Source‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

مفهرسة‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (يفتح نافذة جديدة)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (يفتح نافذة جديدة)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Source‎: Paediatr Anaesth 2009;19(4):364-70.

مفهرسة‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (يفتح نافذة جديدة)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (يفتح نافذة جديدة)

Guzzetta NA, Russell IA, Williams GD.

Source‎: Anesth Analg 2012;115(2):364-78.

مفهرسة‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (يفتح نافذة جديدة)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (يفتح نافذة جديدة)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Source‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

مفهرسة‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (يفتح نافذة جديدة)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (يفتح نافذة جديدة)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Source‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

مفهرسة‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (يفتح نافذة جديدة)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (يفتح نافذة جديدة)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Source‎: J Clin Anesth 2014;26(3):204-11.

مفهرسة‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (يفتح نافذة جديدة)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (يفتح نافذة جديدة)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Source‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

مفهرسة‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (يفتح نافذة جديدة)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (يفتح نافذة جديدة)

Tobias JD, Berkenbosch JW, Russo P.

Source‎: Pediatr Crit Care Med 2003;4(1):49-51.

مفهرسة‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (يفتح نافذة جديدة)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (يفتح نافذة جديدة)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Source‎: J Intensive Care Med 2004;19(5):270-3.

مفهرسة‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (يفتح نافذة جديدة)

Recombinant activated factor VII in cardiac surgery: a systematic review. (يفتح نافذة جديدة)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Source‎: Ann Thorac Surg 2007;83(2):707-14.

مفهرسة‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (يفتح نافذة جديدة)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (يفتح نافذة جديدة)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Source‎: Pediatr Crit Care Med 2009;10(5):572-82.

مفهرسة‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (يفتح نافذة جديدة)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (يفتح نافذة جديدة)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Source‎: Pediatr Cardiol 2013;34(1):119-24.

مفهرسة‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (يفتح نافذة جديدة)

مركزات عامل التخثُّر

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (يفتح نافذة جديدة)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Source‎: Artif Organs 2010;34(11):955-60.

مفهرسة‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (يفتح نافذة جديدة)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (يفتح نافذة جديدة)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Source‎: Eur J Anaesthesiol 2014;31(6):317-26.

مفهرسة‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (يفتح نافذة جديدة)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (يفتح نافذة جديدة)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Source‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

مفهرسة‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (يفتح نافذة جديدة)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (يفتح نافذة جديدة)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Source‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

مفهرسة‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (يفتح نافذة جديدة)

العلاجات الموضعية لوقف النزيف

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (يفتح نافذة جديدة)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Source‎: Ann Surg 2010;251(2):217-28.

مفهرسة‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (يفتح نافذة جديدة)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (يفتح نافذة جديدة)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Source‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

مفهرسة‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (يفتح نافذة جديدة)

اختبارات اللزوجة المرنة لتحديد النزيف الجراحي أو التخثري (تجلط الدم)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (يفتح نافذة جديدة)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Source‎: Ann Card Anaesth 2012;15(1):26-31.

مفهرسة‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (يفتح نافذة جديدة)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (يفتح نافذة جديدة)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Source‎: Artif Organs 2010;34(11):955-60.

مفهرسة‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (يفتح نافذة جديدة)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (يفتح نافذة جديدة)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Source‎: Br J Anaesth 2015;114(1):91-102.

مفهرسة‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (يفتح نافذة جديدة)